BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35930434)

  • 1. The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology.
    Sohaei D; Hollenberg M; Janket SJ; Diamandis EP; Poda G; Prassas I
    Crit Rev Clin Lab Sci; 2023 Jan; 60(1):25-40. PubMed ID: 35930434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?
    Nicolau LAD; Magalhães PJC; Vale ML
    Med Hypotheses; 2020 Oct; 143():109886. PubMed ID: 32504925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
    Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C
    Front Immunol; 2020; 11():2014. PubMed ID: 32849666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
    Garvin MR; Alvarez C; Miller JI; Prates ET; Walker AM; Amos BK; Mast AE; Justice A; Aronow B; Jacobson D
    Elife; 2020 Jul; 9():. PubMed ID: 32633718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose ACEi might be harmful in COVID-19 patients with serious respiratory distress syndrome by leading to excessive bradykinin receptor activation.
    Székács B; Várbíró S; Debreczeni L
    Physiol Int; 2021 Mar; ():. PubMed ID: 33764894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
    Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
    Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19.
    Martens CP; Van Mol P; Wauters J; Wauters E; Gangnus T; Noppen B; Callewaert H; Feyen JHM; Liesenborghs L; Heylen E; Jansen S; Pereira LCV; Kraisin S; Guler I; Engelen MM; Ockerman A; Van Herck A; Vos R; Vandenbriele C; Meersseman P; Hermans G; Wilmer A; Martinod K; Burckhardt BB; Vanhove M; Jacquemin M; Verhamme P; Neyts J; Vanassche T
    EBioMedicine; 2022 Sep; 83():104195. PubMed ID: 35939907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells.
    Sidarta-Oliveira D; Jara CP; Ferruzzi AJ; Skaf MS; Velander WH; Araujo EP; Velloso LA
    Sci Rep; 2020 Nov; 10(1):19522. PubMed ID: 33177594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin-Kallikrein System in Severe COVID-19.
    Mansour E; Palma AC; Ulaf RG; Ribeiro LC; Bernardes AF; Nunes TA; Agrela MV; Bombassaro B; Monfort-Pires M; Camargo RL; Araujo EP; Brunetti NS; Farias AS; Falcão ALE; Santos TM; Trabasso P; Dertkigil RP; Dertkigil SS; Moretti ML; Velloso LA
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33669276
    [No Abstract]   [Full Text] [Related]  

  • 11. "When," "Where," and "How" of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review.
    Kounis NG; Gogos C; de Gregorio C; Hung MY; Kounis SN; Tsounis EP; Assimakopoulos SF; Pourmasumi S; Mplani V; Servos G; Dousdampanis P; Plotas P; Michalaki MA; Tsigkas G; Grammatikopoulos G; Velissaris D; Koniar I
    Balkan Med J; 2024 Jan; 41(1):7-22. PubMed ID: 38173173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID.
    Cooper SL; Boyle E; Jefferson SR; Heslop CRA; Mohan P; Mohanraj GGJ; Sidow HA; Tan RCP; Hill SJ; Woolard J
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19?
    Gouda AS; Mégarbane B
    Drug Dev Res; 2021 Feb; 82(1):38-48. PubMed ID: 32761647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
    Cheng H; Wang Y; Wang GQ
    J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and Lung Mast Cells: The Kallikrein-Kinin Activation Pathway.
    Nagashima S; Dutra AA; Arantes MP; Zeni RC; Klein CK; de Oliveira FC; Piper GW; Brenny ID; Pereira MRC; Stocco RB; Martins APC; de Castro EM; Vaz de Paula CB; Amaral ANM; Machado-Souza C; Baena CP; Noronha L
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies.
    Gando S; Wada T
    Front Immunol; 2021; 12():649122. PubMed ID: 34177896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
    Hu Y; Liu L; Lu X
    Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity.
    Alfaro E; Díaz-García E; García-Tovar S; Zamarrón E; Mangas A; Galera R; Nanwani-Nanwani K; Pérez-de-Diego R; López-Collazo E; García-Río F; Cubillos-Zapata C
    Front Immunol; 2022; 13():909342. PubMed ID: 35812405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
    Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F
    Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE2: The Major Cell Entry Receptor for SARS-CoV-2.
    Scialo F; Daniele A; Amato F; Pastore L; Matera MG; Cazzola M; Castaldo G; Bianco A
    Lung; 2020 Dec; 198(6):867-877. PubMed ID: 33170317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.